Nucleus, a venture studio for psychedelics wholly owned by Iter Investments, will present its Psychedelic Series at Soho House Nashville on Wednesday, July 12, at 7 p.m. Moderated by psychedelics expert Dustin Robinson, Esq. CPA., the panel will feature Guide and Integration Coach Andy Sudbrock and Psychedelic Series founder Samuel Baum.
“Psychedelics” is a loaded term, conjuring images of hippies, music festivals and colorful patterns. However, these substances have been in use for thousands of years, and today are being reevaluated by medical centers, governments and businesses for their therapeutic value. The panelists will discuss the history of the ceremonial use of psychedelics, what’s going on with them today, and what the future holds for these perception-altering substances.
Sudbrock is the founder of The Sacred Path which specializes in life elevation and optimization through carefully designed and curated entheogenic adventure travel retreats and one-on-one integration coaching and guidance. Sudbrock is a Third Wave certified psychedelic integration coach and a skilled ceremony leader who personally practices many of the “Shamanic Arts” including meditation, breathwork, Shinrin-yoku, entheogenic exploration, grounding, flow movement and deep connection.
Baum is a visionary leader and has spent over 20 years as a professional in creative marketing and community building, including top companies in music, art and entertainment. He has been actively working with the growing psychedelic industry since 2019. Baum co-founded the Psychedelic Series to help raise awareness of the incredible potential for the role of psychedelics in mental health, build a community for its advocates, and connect people with opportunities who are interested in supporting and investing in the space.
Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem; and Co-Founder of Nucleus – a platform with various tools to help guide individuals on their mental health journey.
Launched in June 2021 by Robinson and Baum, the Psychedelic Series features experts in the psychedelics space including CEOs, doctors, lawyers and celebrities. The panel started at Soho Beach House Miami and expanded to locations throughout the country including New York, Nashville, Chicago and California, as well as internationally in London and Amsterdam. Past panelists include MAPS Founder Rick Doblin, NBA champion Lamar Odom, Psilera Bioscience CEO Chris Witowski, PhD, Silo Wellness CEO Douglas K. Gordon, and others.
Wednesday, July 12; 7 p.m. CT
Soho House Nashville
500 Houston St., Nashville, TN 37203
The event is private and only open to Soho House members.
Nucleus is a venture studio creating brands in the growing psychedelics industry. Nucleus has built 12 brands that bridge industry gaps in media, data, and technology. The data platform, Neuly, powers the ecosystem while Psychedelic Invest serves as a content network for those curious to learn more about the psychedelics industry. Nucleus has also developed a marketing platform, a directory of practitioners, and a blockchain protocol, to further support the many ways Nucleus can power the industry on its way to help millions of people find the right treatments, experiences, and overall well-being. For more information, visit withnucleus.com.
About Iter Investments:
Iter Investments is an investment firm that deploys capital in and around the burgeoning psychedelic industry. Iter Investments invests with the mission of re-imagining how the mental health and wellness industry delivers care. For more information, visit www.iterinvestments.com or email email@example.com.